BRAND INDIA PLANTATIONS > Spice News > Affordable drug to treat hypertension from Indian spices

Spice News

Affordable drug to treat hypertension from Indian spices

Chennai, June 25, 2014:

An animal study done by scientists in Chennai have revealed that spices and condiments that are commonly used in Indian soups, curries and rasam, when taken in a specific proportion with white lotus petals can lower blood pressure.

The Siddha drug 'venthamarai chooranam,' which is a mixture of cardamom, ginger, cumin seeds, long pepper (thippili), dill (sada kuppi), licorice (adimadhuram) and white lotus petal was able to lower blood pressure in rats during laboratory experiments. Doctors at the Sri Ramachandra University are now preparing for a larger animal study and clinical trials of the Siddha drug. The findings have been published in the science journal Experimental Biology and Medicine.

Indians are genetically predisposed to hypertension as one in four Indians in cities suffer from the disorder. The incidence is about 15 per cent in rural population. Cardiologist Dr S Thanikachalam, who led the research, stated: "Every time I see a patient's case sheet, I underline four causes - smoking, diabetes, hypertension and obesity." People with hypertension are mostly treated with allopathic drugs, but dropouts are high because many find the drugs expensive and some suffer from side effects. "So, we decided to look at the ancient Indian medical literature for answers," he said.

Scientists had first tried out the Siddha powder on rats and have found it effective. "When we gave this chooranam for 63 days and the blood pressure dropped," said C Saravana Babu, a toxicologist who was a part of the research. The drug was successful in making healthy changes in the genes, tissues and blood vessels as per pathological reports.The herbal medicine will be put to further animal and human test, before it can be given to humans, Dr Thanikachalam said.

Copyright © 2010-2016 India Brand Equity Foundation

All material, information, data, images or content on this website is subject to copyright or other applicable intellectual property laws and no part of it can be reproduced in any form (including paper or electronic form) without prior written consent and approval from IBEF. Infringements are subject to prosecution under the applicable laws. For consent related queries and conditions,
please write to